通策医疗
(600763)
| 流通市值：209.06亿 | | | 总市值：209.06亿 |
| 流通股本：4.47亿 | | | 总股本：4.47亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,448,440,275.71 | 744,611,704.47 | 2,873,776,923.07 | 2,233,126,548.77 |
| 营业收入 | 1,448,440,275.71 | 744,611,704.47 | 2,873,776,923.07 | 2,233,126,548.77 |
| 二、营业总成本 | 1,060,903,412.94 | 516,786,428.41 | 2,228,564,644.29 | 1,606,451,888.31 |
| 营业成本 | 858,203,094.57 | 415,447,933.54 | 1,767,306,262.03 | 1,299,312,591.18 |
| 税金及附加 | 3,596,189.92 | 573,523.56 | 5,716,278.42 | 4,103,781.04 |
| 销售费用 | 14,626,161.95 | 6,984,707.73 | 31,941,472.24 | 25,708,384.75 |
| 管理费用 | 139,096,742.92 | 72,558,232.19 | 316,288,401.87 | 200,368,712.64 |
| 研发费用 | 24,306,610.74 | 11,936,367.6 | 58,952,690.28 | 41,050,496.48 |
| 财务费用 | 21,074,612.84 | 9,285,663.79 | 48,359,539.45 | 35,907,922.22 |
| 其中:利息费用 | 18,445,535.45 | 7,775,033.5 | 45,436,507.93 | 32,972,516.68 |
| 其中:利息收入 | 1,196,560.57 | 566,242.46 | 4,097,081.08 | 3,253,316.03 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | 1,417,168.24 | - |
| 加:投资收益 | 27,091,151.24 | 11,195,169.04 | 46,427,350.82 | 37,386,765.97 |
| 资产处置收益 | -123,661.68 | -15,150.28 | 141,002.18 | 62,393.75 |
| 资产减值损失(新) | - | - | 154,517.35 | - |
| 信用减值损失(新) | 85,248.23 | -1,459,025.43 | -1,447,345.72 | 1,487,698.86 |
| 其他收益 | 6,604,894.25 | 2,524,163.23 | 6,727,275.29 | 4,444,244.51 |
| 四、营业利润 | 421,194,494.81 | 240,070,432.62 | 698,632,246.94 | 670,055,763.55 |
| 加:营业外收入 | 79,552.78 | 173,772.26 | 209,910.28 | 250,120.48 |
| 减:营业外支出 | 1,352,515.75 | 349,002.93 | 4,833,104.62 | 2,414,941.64 |
| 五、利润总额 | 419,921,531.84 | 239,895,201.95 | 694,009,052.6 | 667,890,942.39 |
| 减:所得税费用 | 39,619,598.06 | 23,791,802.29 | 121,877,563.17 | 66,130,122.51 |
| 六、净利润 | 380,301,933.78 | 216,103,399.66 | 572,131,489.43 | 601,760,819.88 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 380,301,933.78 | 216,103,399.66 | 572,131,489.43 | 601,760,819.88 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 321,157,553.42 | 183,925,013.61 | 501,426,889.23 | 498,270,940.75 |
| 少数股东损益 | 59,144,380.36 | 32,178,386.05 | 70,704,600.2 | 103,489,879.13 |
| 扣除非经常损益后的净利润 | 317,346,600.28 | 182,428,691.09 | 496,499,501.95 | 494,181,699.08 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.72 | 0.41 | 1.12 | 1.11 |
| (二)稀释每股收益 | 0.72 | 0.41 | 1.12 | 1.11 |
| 八、其他综合收益 | 3,251,806.45 | 0.05 | -109,339,073.44 | -7,667,509.45 |
| 归属于母公司股东的其他综合收益 | 3,251,806.45 | 0.05 | -109,339,073.44 | -7,667,509.45 |
| 九、综合收益总额 | 383,553,740.23 | 216,103,399.71 | 462,792,415.99 | 594,093,310.43 |
| 归属于母公司股东的综合收益总额 | 324,409,359.87 | 183,925,013.66 | 392,087,815.79 | 490,603,431.3 |
| 归属于少数股东的综合收益总额 | 59,144,380.36 | 32,178,386.05 | 70,704,600.2 | 103,489,879.13 |
| 公告日期 | 2025-08-23 | 2025-04-26 | 2025-04-26 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |